Luo, Hui

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial

Cao, Y., Wei, J., Zou, L., Jiang, T., Wang, G., Chen, L., Huang, L., Meng, F., Huang, L., Wang, N., et al. (2020) · Journal of Allergy and Clinical Immunology

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 456

Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response

Qiu, M.-Z., Wang, C., Wu, Z., Zhao, Q., Zhao, Z., Huang, C.-Y., Wu, W., Yang, L.-Q., Zhou, Z.-W., Zheng, Y., et al. (2023) · Signal Transduction and Targeted Therapy

Cancer Immunotherapy and BiomarkersViral-associated cancers and disorders

Cited by 58

Chemotherapy with or Without Anti-EGFR Agents in Left- and Right-Sided Metastatic Colorectal Cancer: An Updated Meta-Analysis

Wang, Z.-X., Wu, H.-X., He, M.-M., Wang, Y.-N., Luo, H.-Y., Ding, P.-R., Xie, D., Chen, G., Li, Y.-H., Wang, F., et al. (2019) · Journal of the National Comprehensive Cancer Network

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 29

AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer

Ye, H., Liu, Y., Wu, K., Luo, H., & Cui, L. (2020) · Cell Communication and Signaling

Colorectal Cancer Treatments and StudiesMetabolism, Diabetes, and Cancer

Cited by 27